Several steroid molecules, including androgens, estrogens, progestagen
s, and corticostereroids, are able to modulate the brain development a
nd functions. These compounds are not always active in their own natur
al molecular configuration but they often need to be transformed at th
e level of their target cells into 'active metabolites'. The two major
metabolic pathways that transform steroids in the brain are: the 5alp
ha-reductase-3alpha-hydroxy-steroid dehydrogenase and the aromatase pa
thways. Both are present in the brain and probably exert specific role
s in the mechanism of action of hormonal steroids. In this article we
briefly review some important findings achieved in our own and in othe
r laboratories concerning the cellular and subcellular brain distribut
ion, development, regulation, cloning, and molecular characterization
of the involved enzymes. In particular, the recent identification of t
wo isoforms of the 5alpha-reductase, the type 1 and type 2, possessing
different structural, biochemical, and distribution characteristics h
as attracted a considerable attention. The few data available on their
brain distribution have been carefully considered. Finally, we have t
ried to focus on the role of the steroid metabolites in the brain, bot
h when they interact with genomic and with membrane receptors. In part
icular, some unpublished observations on the effects of two 5alpha-red
uctase inhibitors on progesterone-induced anesthesia, a phenomenon med
iated through the GABA(A) receptor, are presented. (C) 1997 Elsevier S
cience Inc.